category,datetime,headline,id,image,related,source,summary,url
company,1768411984,"Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade)",138115832,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323538000/image_1323538000.jpg?io=getty-c-w1536,BDX,SeekingAlpha,"Becton, Dickinson stock rallied 30% after its $17.5 billion Waters divestiture. Here's why shares are a ""Hold"" now.",https://finnhub.io/api/news?id=6fbc29b6b2c38d37972eb7ad9357b430cd6c8a45a078cc17f6a6bbf542ca8111
company,1768409220,Becton Dickinson & Co. stock outperforms competitors on strong trading day,138131389,,BDX,MarketWatch,Becton Dickinson & Co. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=01d33c208e974c3a7d9db514e0183effabfb49be680b02384d7392d67307428b
company,1768391400,BD Names Shawn Bevec as Senior Vice President of Investor Relations,138110536,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior vice president of investor relations, effective Jan. 20.",https://finnhub.io/api/news?id=52e9c57594723c3ed3f0bf56dfb90aff81b064305079e54bbb1fad3d52f1d9fa
company,1768388450,BD invests $110m to expand US prefillable syringe production,138110537,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD will introduce Neopak Glass Prefillable Syringe manufacturing at its facility in Columbus, Nebraska.",https://finnhub.io/api/news?id=35049bc77592496a2469badfa5ba093b916c0e7095a7b8017403dcb10d4d275e
company,1768360883,Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price Declines,138094456,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"If you are wondering whether Becton Dickinson's current share price lines up with its underlying worth, you are not alone. This article looks at what the market might be pricing in. The stock recently closed at US$201.52, with returns of a 1.9% decline over 7 days, 0.3% over 30 days, 3.4% year to date, a 12.7% decline over 1 year and a 17.0% decline over 3 years. Together, these figures give a mixed picture of how the market has been reassessing the shares. Recent news around Becton...",https://finnhub.io/api/news?id=bf185422e949e4802911d76685d281a761dbfc8fd0e504704651e56beecb6e50
company,1768350796,Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans,138094457,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"Becton Dickinson (BDX) has been drawing attention after recent share performance that includes a small daily decline and mixed moves over the past week, month and past three months, prompting investors to reassess the medical supplier. See our latest analysis for Becton Dickinson. At a share price of $201.52, Becton Dickinson’s recent 7.9% 90 day share price return contrasts with a 12.7% decline in 1 year total shareholder return. This suggests shorter term momentum while longer term returns...",https://finnhub.io/api/news?id=ffb711a87777fe4d94065a643ef770a726354a20e87543542f593d519dfc1b21
